Technology in the management of type 1 diabetes mellitus — current status and future prospects

[1]  R. Bergenstal.  Continuous glucose monitoring: transforming diabetes management step by step , 2018, The Lancet.

[2]  R. Ajjan,et al.  Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests. , 2018, Diabetes research and clinical practice.

[3]  N. Oliver,et al.  A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[4]  J. Speight,et al.  Distal technologies and type 1 diabetes management. , 2017, The lancet. Diabetes & endocrinology.

[5]  Eyal Dassau,et al.  Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control‐based fully‐automated artificial pancreas in patients with type 1 diabetes: a pilot study , 2017, Diabetes, obesity & metabolism.

[6]  Eyal Dassau,et al.  International Consensus on Use of Continuous Glucose Monitoring , 2017, Diabetes Care.

[7]  O. Kordonouri,et al.  Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes , 2017, JAMA.

[8]  S. Roberts,et al.  Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[9]  P. Lapuerta,et al.  Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes , 2017, The New England journal of medicine.

[10]  R. Hovorka,et al.  Finding the right route for insulin delivery – an overview of implantable pump therapy , 2017, Expert opinion on drug delivery.

[11]  M. Weiss,et al.  Development of glucose-responsive ‘smart’ insulin systems , 2017, Current opinion in endocrinology, diabetes, and obesity.

[12]  LinaresFrancisca,et al.  Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study) , 2017 .

[13]  B. Perkins,et al.  Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. , 2017, The lancet. Diabetes & endocrinology.

[14]  G. Forlenza,et al.  Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use. , 2017, Diabetes technology & therapeutics.

[15]  Joseph A Cafazzo,et al.  A Mobile App for the Self-Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled Trial , 2017, JMIR mHealth and uHealth.

[16]  J. McKnight,et al.  Flash Glucose Monitoring is associated with improved glycaemic control but use is largely limited to more affluent people in a UK diabetes centre , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[17]  W NewmanMark,et al.  Real-World Use and Self-Reported Health Outcomes of a Patient-Designed Do-it-Yourself Mobile Technology System for Diabetes: Lessons for Mobile Health , 2017 .

[18]  Tadej Battelino,et al.  Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial , 2017, Diabetes Care.

[19]  R. Stimson,et al.  Flash Glucose Monitoring Improves Outcomes in a Type 1 Diabetes Clinic , 2017, Journal of diabetes science and technology.

[20]  Benyamin Grosman,et al.  Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes , 2017, Diabetes technology & therapeutics.

[21]  Xin Sun,et al.  Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy , 2017, JMIR mHealth and uHealth.

[22]  Rodica Pop-Busui,et al.  REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Well-Controlled Adults With Type 1 Diabetes , 2017 .

[23]  J. Edge,et al.  An alternative sensor-based method for glucose monitoring in children and young people with diabetes , 2017, Archives of Disease in Childhood.

[24]  Howard Wolpert,et al.  Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial , 2017, JAMA.

[25]  Sofia Dahlqvist,et al.  Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial , 2017, JAMA.

[26]  Steven V. Edelman,et al.  Regulation Catches Up to Reality , 2017, Journal of diabetes science and technology.

[27]  Steven V. Edelman,et al.  Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes , 2016, Journal of diabetes science and technology.

[28]  G. Olveira,et al.  The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes , 2016, Journal of diabetes.

[29]  ChenXiaoping,et al.  "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus. , 2017 .

[30]  F. Pouwer,et al.  The Use of Mobile Applications Among Adolescents with Type 1 Diabetes: Results from Diabetes MILES Youth-Australia. , 2016, Diabetes technology & therapeutics.

[31]  P. Geelhoed-Duijvestijn,et al.  Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial , 2016, The Lancet.

[32]  J. Hans DeVries,et al.  Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial , 2016, Diabetes Care.

[33]  R. Viner,et al.  Young people with Type 1 diabetes of non‐white ethnicity and lower socio‐economic status have poorer glycaemic control in England and Wales , 2016, Diabetic medicine : a journal of the British Diabetic Association.

[34]  J. Hewitt,et al.  Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-management of Diabetes? A Systematic Review, Meta-analysis, and GRADE of 14 Randomized Trials , 2016, Diabetes Care.

[35]  Bruce W Bode,et al.  Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes. , 2016, JAMA.

[36]  Alison B. Evert,et al.  Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[37]  Dana Lewis,et al.  Real-World Use of Open Source Artificial Pancreas Systems , 2016, Journal of diabetes science and technology.

[38]  C. Toumazou,et al.  Clinical Safety and Feasibility of the Advanced Bolus Calculator for Type 1 Diabetes Based on Case-Based Reasoning: A 6-Week Nonrandomized Single-Arm Pilot Study. , 2016, Diabetes technology & therapeutics.

[39]  C. de Beaufort,et al.  Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry , 2016, Pediatric diabetes.

[40]  I. Raz,et al.  Improvement in Glucose Control in Difficult-to-Control Patients With Diabetes Using a Novel Flash Glucose Monitoring Device , 2016, Journal of diabetes science and technology.

[41]  Ahmad Haidar,et al.  The role of glucagon in the artificial pancreas. , 2016, The lancet. Diabetes & endocrinology.

[42]  S. Davis,et al.  Novel Methods of Insulin Replacement: The Artificial Pancreas and Encapsulated Islets. , 2016, Reviews on recent clinical trials.

[43]  Irl B Hirsch,et al.  CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[44]  R. Beck,et al.  Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections , 2016, Diabetes Care.

[45]  Joyce M Lee,et al.  A Patient-Designed Do-It-Yourself Mobile Technology System for Diabetes: Promise and Challenges for a New Era in Medicine. , 2016, JAMA.

[46]  Stuart A. Weinzimer,et al.  Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide , 2016, Diabetes Care.

[47]  Peter G. Jacobs,et al.  Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions , 2016, Journal of diabetes science and technology.

[48]  Bruce W Bode,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[49]  L. Laffel.  Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies. , 2016, Diabetes technology & therapeutics.

[50]  Steven McCanne,et al.  A case study in open source innovation: developing the Tidepool Platform for interoperability in type 1 diabetes management , 2015, J. Am. Medical Informatics Assoc..

[51]  Claudio Cobelli,et al.  2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. , 2015, The lancet. Diabetes & endocrinology.

[52]  Roman Hovorka,et al.  Home Use of an Artificial Beta Cell in Type 1 Diabetes. , 2015, The New England journal of medicine.

[53]  S. Amiel,et al.  Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[54]  T. Bailey,et al.  The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System , 2015, Diabetes technology & therapeutics.

[55]  W. BeckRoy.  Downloading Diabetes Device Data: Empowering Patients to Download at Home to Achieve Better Outcomes. , 2015 .

[56]  S. Garg,et al.  Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study , 2015, Diabetes technology & therapeutics.

[57]  Ahmad Haidar,et al.  Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. , 2015, The lancet. Diabetes & endocrinology.

[58]  Aaron B. Neinstein,et al.  A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data , 2015, Diabetes technology & therapeutics.

[59]  Eyal Dassau,et al.  Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial. , 2015, The Journal of clinical endocrinology and metabolism.

[60]  A. Rawshani,et al.  Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study , 2015, BMJ : British Medical Journal.

[61]  B. Wayne Bequette,et al.  Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis , 2015, Diabetes Care.

[62]  Rajiv V Shah,et al.  Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. , 2015, Diabetes technology & therapeutics.

[63]  D. Klonoff.  Trends in FDA Regulation of Software to Control Insulin Dosing , 2015, Journal of diabetes science and technology.

[64]  G. Freckmann,et al.  Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings , 2015, Journal of diabetes science and technology.

[65]  Stephen D Patek,et al.  Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. , 2015, Diabetes technology & therapeutics.

[66]  K. Nørgaard,et al.  Performance and Acceptability of a Combined Device for Insulin Infusion and Glucose Sensing in the Home Setting , 2015, Journal of diabetes science and technology.

[67]  J. OrrChristine,et al.  Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus. , 2015 .

[68]  T. Bailey,et al.  Clinical Accuracy of a Continuous Glucose Monitoring System With an Advanced Algorithm , 2014, Journal of diabetes science and technology.

[69]  J K Mader,et al.  Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions , 2014, Diabetes, obesity & metabolism.

[70]  M. Cowie.  National Institute for Health and Care Excellence. , 2015, European heart journal.

[71]  Reinhard W. Holl,et al.  Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries , 2015, Diabetologia.

[72]  T. Danne,et al.  Insulin treatment in children and adolescents with diabetes , 2009, Pediatric diabetes.

[73]  C. de Beaufort,et al.  Assessment and monitoring of glycemic control in children and adolescents with diabetes , 2014 .

[74]  David M Nathan,et al.  Outpatient glycemic control with a bionic pancreas in type 1 diabetes. , 2014, The New England journal of medicine.

[75]  Neesha Ramchandani,et al.  Role of Glucagon-Like Peptide-1 Analogue Versus Amylin as an Adjuvant Therapy in Type 1 Diabetes in a Closed Loop Setting With ePID Algorithm , 2014, Journal of diabetes science and technology.

[76]  Darrell M. Wilson,et al.  A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes , 2014, Diabetes Care.

[77]  M. Joubert,et al.  Cross-sectional Survey and Retrospective Analysis of a Large Cohort of Adults With Type 1 Diabetes With Long-Term Continuous Subcutaneous Insulin Infusion Treatment , 2014, Journal of diabetes science and technology.

[78]  Bruce W Bode,et al.  Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[79]  W. Ward,et al.  A review of artificial pancreas technologies with an emphasis on bi‐hormonal therapy , 2013, Diabetes, obesity & metabolism.

[80]  R. Beck,et al.  Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. , 2013, Diabetes technology & therapeutics.

[81]  K. Barnard,et al.  Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control , 2013, Diabetes Care.

[82]  T. Jones,et al.  Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. , 2013, JAMA.

[83]  Stephanie R. Johnson,et al.  Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case–control study , 2013, Diabetologia.

[84]  D. Klonoff,et al.  Threshold-based insulin-pump interruption for reduction of hypoglycemia. , 2013, The New England journal of medicine.

[85]  J. McGill,et al.  Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants , 2013, Diabetes Care.

[86]  D. Golicki,et al.  The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus - systematic review. , 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[87]  T. Pieber,et al.  Periodic extraction of interstitial fluid from the site of subcutaneous insulin infusion for the measurement of glucose: a novel single-port technique for the treatment of type 1 diabetes patients. , 2013, Diabetes technology & therapeutics.

[88]  Marlena Błazik,et al.  The effect of bolus and food calculator Diabetics on glucose variability in children with type 1 diabetes treated with insulin pump: the results of RCT , 2012, Pediatric diabetes.

[89]  W. Ward,et al.  Stable Liquid Glucagon Formulations for Rescue Treatment and Bi-Hormonal Closed-Loop Pancreas , 2012, Current Diabetes Reports.

[90]  B. Olsen,et al.  The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial , 2012, Diabetologia.

[91]  E. Bass,et al.  Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus , 2012, Annals of Internal Medicine.

[92]  Eirik Årsand,et al.  Improving Diabetes Care for Young People With Type 1 Diabetes Through Visual Learning on Mobile Phones: Mixed-Methods Study , 2012, Journal of medical Internet research.

[93]  Anirban Roy,et al.  Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes , 2012, Diabetes Care.

[94]  J. Cafazzo,et al.  Design of an mHealth App for the Self-management of Adolescent Type 1 Diabetes: A Pilot Study , 2012, Journal of medical Internet research.

[95]  D. Golicki,et al.  Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials. , 2012, European journal of endocrinology.

[96]  Lotty Hooft,et al.  Continuous glucose monitoring systems for type 1 diabetes mellitus. , 2012, The Cochrane database of systematic reviews.

[97]  V. Basevi,et al.  Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.

[98]  Martin Holder,et al.  Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. , 2011, Diabetes technology & therapeutics.

[99]  Michael A. Wood,et al.  Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study , 2011, Diabetes Care.

[100]  Giovanni Luca,et al.  Long-Term Metabolic and Immunological Follow-Up of Nonimmunosuppressed Patients With Type 1 Diabetes Treated With Microencapsulated Islet Allografts , 2011, Diabetes Care.

[101]  D. Klonoff,et al.  Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[102]  David Kerr,et al.  Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia , 2011, Diabetes Care.

[103]  Alex J Sutton,et al.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data , 2011, BMJ : British Medical Journal.

[104]  L. B. E. A. Hoeks,et al.  Real‐time continuous glucose monitoring system for treatment of diabetes: a systematic review , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[105]  M. Phillip,et al.  Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes , 2011, Diabetes Care.

[106]  J. Rosenbauer,et al.  Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes , 2011, Pediatric diabetes.

[107]  R. Valdés-González,et al.  Long‐term follow‐up of patients with type 1 diabetes transplanted with neonatal pig islets , 2010, Clinical and experimental immunology.

[108]  Howard C. Zisser,et al.  The OmniPod Insulin Management System: the latest innovation in insulin pump therapy , 2010, Diabetes therapy : research, treatment and education of diabetes and related disorders.

[109]  George Dailey,et al.  Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. , 2010, The New England journal of medicine.

[110]  E. Renard.  Insulin pump use in Europe. , 2010, Diabetes technology & therapeutics.

[111]  Robert G. Sutherlin,et al.  A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.

[112]  Roy W Beck,et al.  Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Nondiabetic Individuals , 2010, Diabetes Care.

[113]  Janet M. Allen,et al.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2010, The Lancet.

[114]  E. Atlas,et al.  MD-Logic Artificial Pancreas System , 2010, Diabetes Care.

[115]  N. Marchionni,et al.  Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis , 2010, Acta Diabetologica.

[116]  M. Ellmerer,et al.  Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients With Type 1 Diabetes , 2009, Diabetes Care.

[117]  R. Beck.  Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment , 2009, Diabetes Care.

[118]  Yogish C Kudva,et al.  Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. , 2009, The Journal of clinical endocrinology and metabolism.

[119]  H. Szajewska,et al.  Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta‐analysis of randomized control trials , 2009, Pediatric diabetes.

[120]  David A Hanauer,et al.  Computerized Automated Reminder Diabetes System (CARDS): e-mail and SMS cell phone text messaging reminders to support diabetes management. , 2009, Diabetes technology & therapeutics.

[121]  F. Ovalle,et al.  Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes , 2009 .

[122]  Michael O'Grady,et al.  Continuous glucose monitoring and intensive treatment of type 1 diabetes. , 2008, The New England journal of medicine.

[123]  F. Cameron,et al.  Optimizing Postprandial Glycemia in Pediatric Patients With Type 1 Diabetes Using Insulin Pump Therapy , 2008, Diabetes Care.

[124]  A J Sutton,et al.  Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[125]  Robert Cuddihy,et al.  Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. , 2008, Diabetes technology & therapeutics.

[126]  A. Berghold,et al.  Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis , 2008, Diabetologia.

[127]  J. Leahy,et al.  Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .

[128]  D. Golicki,et al.  Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis , 2008, Diabetologia.

[129]  C. Buchanan,et al.  Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation , 2007, Xenotransplantation.

[130]  G. Steil,et al.  Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.

[131]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[132]  R. Gabbay,et al.  Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system. , 2005, Diabetes technology & therapeutics.

[133]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[134]  J. Ireland,et al.  CONVENIENT POCKET INSULIN SYRINGE , 1981, The Lancet.

[135]  H Keen,et al.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. , 1978, British medical journal.